Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Videos
The Evolving Therapy Landscape of MSI-High Colon Cancer
12/05/2019
Tanios Bekaii-Saab, MD, talks about the evolving therapy landscape of MSI-high colon cancer.
Tanios Bekaii-Saab, MD, talks about the evolving therapy landscape of MSI-high colon cancer.
Tanios Bekaii-Saab, MD, talks...
12/05/2019
Oncology
Debates and Roundtables
Expert Roundtable: Maintenance Olaparib Extends PFS in BRCA-Mutated Pancreatic Cancer
11/13/2019
Eileen O’Reilly, MD; Talia Golan, MD; Pascal Hammel, MD; and Teresa Macarulla, MD, PhD, discuss the findings of the POLO clinical trial.
Eileen O’Reilly, MD; Talia Golan, MD; Pascal Hammel, MD; and Teresa Macarulla, MD, PhD, discuss the findings of the POLO clinical trial.
Eileen O’Reilly, MD; Talia...
11/13/2019
Oncology
Test Your Knowledge
Quiz: Is 3-Month Capecitabine Plus Oxaliplatin Appropriate for CRC?
10/28/2019
True or False: For patients with CRC, a 3-month chemo regimen of capecitabine plus oxaliplatin may be the most appropriate treatment option, especially among those with low-risk disease.
True or False: For patients with CRC, a 3-month chemo regimen of capecitabine plus oxaliplatin may be the most appropriate treatment option, especially among those with low-risk disease.
True or False: For patients with...
10/28/2019
Oncology
Videos
Ivosidenib Shows Clinical Benefit in IDH1-Mutant Advanced Cholangiocarcinoma
10/23/2019
Ghassan Abou-Alfa, MD, MBA, discusses the results from the ClarIDHy trial, which show the potential for ivosidenib as a new standard for patients with IDH1-mutant advanced cholangiocarcinoma.
Ghassan Abou-Alfa, MD, MBA, discusses the results from the ClarIDHy trial, which show the potential for ivosidenib as a new standard for patients with IDH1-mutant advanced cholangiocarcinoma.
Ghassan Abou-Alfa, MD, MBA,...
10/23/2019
Oncology
Videos
Career Paths in Medical Oncology
10/16/2019
Robert Maki, MD, PhD, breaks down career path options for fellows in medical oncology at the 2019 Great Debates and Updates in GI Malignancies meeting.
Robert Maki, MD, PhD, breaks down career path options for fellows in medical oncology at the 2019 Great Debates and Updates in GI Malignancies meeting.
Robert Maki, MD, PhD, breaks...
10/16/2019
Oncology
Conventional Chemoradiation Therapy Appropriate for Rectal Cancer Treatment
10/16/2019
Noam VanderWalde, MD, MS, debates that conventional chemoradiation followed by total mesorectal excision and adjuvant chemo is the correct approach for rectal cancer.
Noam VanderWalde, MD, MS, debates that conventional chemoradiation followed by total mesorectal excision and adjuvant chemo is the correct approach for rectal cancer.
Noam VanderWalde, MD, MS,...
10/16/2019
Oncology
Videos
The Role of ctDNA in Gastrointestinal Cancer
10/16/2019
Scott Kopetz, MD, PhD, FACP, discusses the role of circulating tumor DNA (ctDNA) in gastrointestinal cancer.
Scott Kopetz, MD, PhD, FACP, discusses the role of circulating tumor DNA (ctDNA) in gastrointestinal cancer.
Scott Kopetz, MD, PhD, FACP,...
10/16/2019
Oncology
Videos
PARP Inhibitor Maintenance Therapy for Pancreatic Cancer With BRCA Mutation
09/14/2019
Eileen O'Reilly, MD, debates in favor of using PARP inhibitors as maintenance therapy for BRCA mutation–positive pancreatic cancer.
Eileen O'Reilly, MD, debates in favor of using PARP inhibitors as maintenance therapy for BRCA mutation–positive pancreatic cancer.
Eileen O'Reilly, MD, debates in...
09/14/2019
Oncology
Videos
Novel Therapy Options for Patients With GISTs
09/14/2019
Robert G. Maki, MD, PhD, provides an update on the new treatment options available for GISTs.
Robert G. Maki, MD, PhD, provides an update on the new treatment options available for GISTs.
Robert G. Maki, MD, PhD,...
09/14/2019
Oncology
Videos
Targeted Therapy as Early Treatment for BRAF V600E-Mutated CRC
09/13/2019
Scott Kopetz, MD, PhD, FACP, discusses using targeted therapy earlier in the treatment of patients with CRC and BRAF V600E mutation.
Scott Kopetz, MD, PhD, FACP, discusses using targeted therapy earlier in the treatment of patients with CRC and BRAF V600E mutation.
Scott Kopetz, MD, PhD, FACP,...
09/13/2019
Oncology

Advertisement

Advertisement

Advertisement

Section Editor

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center, New York

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement